Friday 6 November 2026
Export INNV’s income statement to Excel — free account
InnovAge Holding Corp.
INNV Healthcare Medical Care Facilities
InnovAge Holding Corp.’s revenue for fiscal 2026 (year ended June 2026) was $989.7 million, up 15.9% from fiscal 2025.
- Revenue
- +12.1%
- EPS
- +155.0%
- Free cash flow
- +622.8%
- Total debt
- −16.7%
Quarter to September 2026, against a year earlier
9.04
0.75
−7.66%
Follow INNV
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
9 | 6 | 6 | 7 |
| 2.50% | (4.85%) | (1.06%) | 3.54% | ||
| 1.23% | (2.14%) | (0.47%) | 1.68% | ||
ROIC |
2.90% | (3.84%) | 1.06% | 6.05% | |
Return on Tangible Assets |
3.21% | (6.75%) | (1.44%) | 4.61% | |
Average Days of Receivables |
9.81 | 12.29 | 16.84 | 9.44 | |
Free Cash Flow per Share |
0.37 | 0.34 | 0.40 | 0.56 | |
Free Cash Flow |
49.75 | 46.28 | 54.12 | 76.31 | |
Capital Expenditures |
(9.16) | (6.15) | (10.59) | (13.22) | |
| Other line items | |||||
Cash ROIC |
11.03% | 10.64% | 12.40% | 16.05% | |
Accounts Receivable Turnover |
23.56 | 23.82 | 23.19 | 38.56 | |
Accounts Payable Turnover |
12.80 | 8.22 | 7.93 | 10.28 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
27.98 | 51.89 | 55.26 | 47.21 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.35) | 0.14 | (3.57) | 0.01 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
16.72% | 20.31% | 20.29% | 19.71% | |
Share Based Compensation of Revenue |
0.78% | 0.72% | 0.71% | 0.64% | |
Interest Coverage |
1.81 | (1.96) | 0.61 | 4.63 | |
Operating CF/Net income |
9.10 | (4.52) | (25.51) | 9.95 | |
Depreciation/Fixed assets |
0.12 | 0.11 | 0.13 | 0.14 | |
Capex/Depreciation |
(0.47) | (0.33) | (0.48) | (0.59) | |
Revenue per Share |
6.75 | 6.99 | 7.29 | 7.47 | |
Operating CF per Share |
0.43 | 0.39 | 0.48 | 0.66 | |
Capex per Share |
(0.07) | (0.05) | (0.08) | (0.10) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 |
Columns are period end dates · fundamentals updated 5 Nov 2026